Risk factors for a severe disease course in children with SARS-COV-2 infection following hematopoietic cell transplantation in the pre-Omicron period: a prospective multinational Infectious Disease Working Party from the European Society for Blood and Marrow Transplantation group (EBMT) and the Spanish Group of Hematopoietic Stem Cell Transplantation (GETH) study
Authors:
- Dina AverbuchDADina Averbuch
- Rafael de la CamaraRCRafael de la Camara
- Tatiana A. BykovaTBTatiana A. Bykova
- Marianne IfversenMIMarianne Ifversen
- Mouhab AyasMAMouhab Ayas
- Amir Ali HamidiehAmir Ali Hamidieh
- Herbert PichlerHPHerbert Pichler
- Antonio Perez-MartinezAntonio Perez-Martinez
- Simone CesaroSimone Cesaro
Open Access
- 27 February 2023
- journal article
- research article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 58 (5) , 558-566
Abstract
Risk factors for severe SARS-Cov-2 infection course are poorly described in children following hematopoietic cell transplantation (HCT). In this international study, we analyzed factors associated with a severe course (intensive care unit (ICU) admission and/or mortality) in post-HCT children. Eighty-nine children (58% male; median age 9 years (min-max 1–18)) who received an allogeneic (85; 96%) or an autologous (4; 4%) HCT were reported from 28 centers (18 countries). Median time from HCT to SARS-Cov-2 infection was 7 months (min-max 0–181). The most common clinical manifestations included fever (37; 42%) and cough (26; 29%); 37 (42%) were asymptomatic. Nine (10%) children following allo-HCT required ICU care. Seven children (8%) following allo-HCT, died at a median of 22 days after SARS-Cov-2 diagnosis. In a univariate analysis, the probability of a severe disease course was higher in allo-HCT children with chronic GVHD, non-malignant disease, immune suppressive treatment (specifically, mycophenolate), moderate immunodeficiency score, low Lansky score, fever, cough, coinfection, pulmonary radiological findings, and high C-reactive protein. In conclusion, SARS-Cov-2 infection in children following HCT was frequently asymptomatic. Despite this, 10% needed ICU admission and 8% died in our cohort. Certain HCT, underlying disease, and SARS-Cov-2 related factors were associated with a severe disease course.Keywords
This publication has 25 references indexed in Scilit:
- Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort studyThe Lancet Haematology, 2021
- COVID-19 Trends Among Persons Aged 0–24 Years — United States, March 1–December 12, 2020MMWR. Morbidity and Mortality Weekly Report, 2021
- Characterization of COVID‐19 disease in pediatric oncology patients: The New York‐New Jersey regional experiencePediatric Blood & Cancer, 2020
- Impact of the First Wave of COVID-19 on Pediatric Oncology and Hematology: A Report from the French Society of Pediatric OncologyCancers, 2020
- COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort studyThe Lancet Child & Adolescent Health, 2020
- Characteristics and Outcomes of Children With Coronavirus Disease 2019 (COVID-19) Infection Admitted to US and Canadian Pediatric Intensive Care UnitsJAMA Pediatrics, 2020
- Initial report on Spanish pediatric oncologic, hematologic, and post stem cell transplantation patients during SARS‐CoV‐2 pandemicPediatric Blood & Cancer, 2020
- A multicenter investigation of respiratory syncytial viral infection in children with hematopoietic cell transplantationTransplant Infectious Disease, 2018
- Significant Transplantation-Related Mortality from Respiratory Virus Infections within the First One Hundred Days in Children after Hematopoietic Stem Cell TransplantationTransplantation and Cellular Therapy, 2015
- Immunodeficiency scoring index to predict poor outcomes in hematopoietic cell transplant recipients with RSV infectionsBlood, 2014